Table of Content

1. INTRODUCTION
1.1 INTRODUCTION
1.2 OBJECTIVES OF THE STUDY

2. RESEARCH METHODOLOGY

3. MARKET OVERVIEW
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 RISING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASE
IN CHINA
3.2.2 INCREASING NUMBER OF HOSPITALS IN CHINA
3.2.3 FAVORABLE GOVERNMENT INITIATIVES
3.3 OPPORTUNITIES
3.3.1 USE OF CLOUD-BASED SOLUTIONS
3.4 CHALLENGES
3.4.1 INTEGRATION AND INTEROPERABILITY

4. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY SYSTEM
4.1 INTEGRATED SYSTEMS
4.2 STANDALONE SYSTEMS

5. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY COMPONENT
5.1 SOFTWARE
5.2 SERVICES
5.3 HARDWARE

6. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET,
BY END USER ANALYSIS
6.1 INTRODUCTION
6.2 L3A HOSPITALS
6.3 L3B & L2 HOSPITALS
6.4 LEVEL 1 HOSPITALS
?

7. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET,
BY END USER ANALYSIS
7.1 MARKET SHARE ANALYSIS, 2018
7.2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS, BY HOSPITAL TYPE (2018)

8. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, COMPANY PROFILES
8.1 PHILIPS HEALTHCARE
8.1.1 COMPANY OVERVIEW
8.1.2 PRODUCTS OFFERED IN CHINA
8.1.3 BUSINESS OVERVIEW
8.1.4 SWOT ANALYSIS
8.1.5 STRATEGY
8.2 CREALIFE MEDICAL TECHNOLOGY

8. 2.1 COMPANY OVERVIEW

8. 2.2 PRODUCTS OFFERED IN CHINA

8. 2.3 SWOT ANALYSIS

8. 2.4 STRATEGY

8. 3 CENTRAL DATA NETWORKS

8. 3.1 COMPANY OVERVIEW

8. 3.2 PRODUCTS OFFERED IN CHINA

8. 3.3 SWOT ANALYSIS

8. 3.4 STRATEGY

8. 4 ESAOTE CHINA LTD.

8. 4.1 COMPANY OVERVIEW

8. 4.2 PRODUCTS OFFERED IN CHINA

8. 5 INFINITT HEALTHCARE CO., LTD.

8. 5.1 COMPANY OVERVIEW

8. 5.2 PRODUCTS OFFERED IN CHINA

9. KEY INSIGHTS FROM INDUSTRY PARTICIPANTS

10 APPENDIX
10.1 DISCUSSION GUIDE
10.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
10.3 RELATED REPORTS
10.4 AUTHORS DETAILS



List of Figures



FIGURE 1 DATA TRIANGULATION METHODOLOGY
FIGURE 2 MORTLITY RATE DUE TO HEART DISEASE IN CHINA
FIGURE 3 NUMBER OF HOSPITALS IN CHINA (IN THOUSAND)
FIGURE 4 PRIVATE VS. PUBLIC HOSPITALS IN CHINA (IN THOUSAND)
FIGURE 5 HEALTHCARE EXPENDITURE IN CHINA (IN USD)
FIGURE 6 CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS BY KEY PLAYERS, 2018
FIGURE 7 CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS BY HOSPITAL TYPE, 2018
FIGURE 8 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2018)

 

List of Tables



TABLE1 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY SYSTEM 2017–2024 (USD MILLION)
TABLE 2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 3 NUMBER OF HOSPITALS IN CHINA, 2009–2024
TABLE 4 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY END USER 2017–2024 (USD MILLION)
TABLE 5 INCREASING NUMBER OF L3A HOSPITALS IN CHINA, 2009–2024
TABLE 6 INCREASING NUMBER OF L3B & L2 HOSPITALS IN CHINA, 2009–2024
TABLE 7 CHINA: AVERAGE SELLING PRICE OF CARDIOVASCULAR INFORMATION TECHNOLOGY, BY END USER (USD MILLION)